Exosomes from Blood Carry RNA Signatures of Liver Cancer

A small study finds that the tiny extracellular vesicles from patients with hepatocellular carcinoma have RNA content distinct from patients with cirrhosis only.

Written byEmma Yasinski
| 2 min read
exosome liver cancer hepatocellular carcinoma RNA cirrhosis

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, MELETIOS VERRAS

RNA sequencing may help doctors diagnose hepatocellular carcinoma earlier, according to preliminary data presented Sunday (March 31) at the American Association for Cancer Research annual meeting in Atlanta, Georgia.

HCC is the most common type of liver cancer, accounting for 65 percent of cases in the United States. Chronic hepatitis B and C infections, alcohol-related liver scarring, and non-alcoholic fatty liver disease are the primary risk factors for the disease. In the United States, the incidence of HCC rose from 1.4 out of 100,000 cases per year in the late 1970s to 6.2 out of 100,000 cases in 2011 and is expected to continue to increase for at least another decade as patients struggle with obesity and hepatitis B. Liver scarring, known as cirrhosis, which can occur as a result of any insult to the organ, puts patients at high risk for developing HCC, with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies